Health Triage is an Italian deep tech company that develops artificial intelligence solutions to make cancer prevention more timely, accessible and precise. Founded in 2020, it works to support physicians and healthcare facilities with reliable technologies capable of improving clinical decisions at the most critical moments. Through proprietary deep learning algorithms and an interdisciplinary approach that integrates clinical, technical and scientific expertise, Health Triage designs devices capable of automating part of the diagnostic process, reducing workloads and improving the quality of diagnoses.
The strength of Health Triage lies in its authoritative and global governance. The company is part of the Fin Posillipo S.p.A. group, an industrial organisation that oversees the entire clinical research supply chain with a widespread presence across five continents, over 800 employees and a turnover of 800 million euros in the healthcare sector. Further reinforcing this profile of excellence is the participation of Fondazione ENEA Tech & Biomedical, which certifies its strategic value in the national technology transfer landscape.
Health Triage is currently focused on two main projects:
- BreastNegative, a medical device that automatically identifies negative mammograms in screening programmes;
- Prostate V-Bio, a non-invasive MRI-based system capable of classifying prostate cancer according to the Gleason Grade.
Ethics, scientific rigour and clinical validation are the foundation of every choice we make.




























